Overactive Bladder Therapeutics Market
1 Study Coverage
1.1 Overactive Bladder (OAB) Therapeutics Product Introduction
1.2 Global Overactive Bladder (OAB) Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Overactive Bladder (OAB) Therapeutics Sales in US$ Million for the Year 2017-2028
1.2.2 Global Overactive Bladder (OAB) Therapeutics Sales in Volume for the Year 2017-2028
1.3 United States Overactive Bladder (OAB) Therapeutics Outlook 2017 VS 2022 VS 2028
1.3.1 United States Overactive Bladder (OAB) Therapeutics Sales in US$ Million for the Year 2017-2028
1.3.2 United States Overactive Bladder (OAB) Therapeutics Sales in Volume for the Year 2017-2028
1.4 Overactive Bladder (OAB) Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Overactive Bladder (OAB) Therapeutics in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Overactive Bladder (OAB) Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Overactive Bladder (OAB) Therapeutics Market Dynamics
1.5.1 Overactive Bladder (OAB) Therapeutics Industry Trends
1.5.2 Overactive Bladder (OAB) Therapeutics Market Drivers
1.5.3 Overactive Bladder (OAB) Therapeutics Market Challenges
1.5.4 Overactive Bladder (OAB) Therapeutics Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Overactive Bladder (OAB) Therapeutics Market Segment by Type
2.1.1 Anticholinergic Agents
2.1.2 Beta-3 Adrenoreceptor Agonists
2.2 Global Overactive Bladder (OAB) Therapeutics Market Size by Type
2.2.1 Global Overactive Bladder (OAB) Therapeutics Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Overactive Bladder (OAB) Therapeutics Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Overactive Bladder (OAB) Therapeutics Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Overactive Bladder (OAB) Therapeutics Market Size by Type
2.3.1 United States Overactive Bladder (OAB) Therapeutics Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Overactive Bladder (OAB) Therapeutics Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Overactive Bladder (OAB) Therapeutics Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Overactive Bladder (OAB) Therapeutics Market Segment by Application
3.1.1 Hosptial
3.1.2 Clinci
3.1.3 Other
3.2 Global Overactive Bladder (OAB) Therapeutics Market Size by Application
3.2.1 Global Overactive Bladder (OAB) Therapeutics Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Overactive Bladder (OAB) Therapeutics Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Overactive Bladder (OAB) Therapeutics Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Overactive Bladder (OAB) Therapeutics Market Size by Application
3.3.1 United States Overactive Bladder (OAB) Therapeutics Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Overactive Bladder (OAB) Therapeutics Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Overactive Bladder (OAB) Therapeutics Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Overactive Bladder (OAB) Therapeutics Competitor Landscape by Company
4.1 Global Overactive Bladder (OAB) Therapeutics Market Size by Company
4.1.1 Top Global Overactive Bladder (OAB) Therapeutics Manufacturers Ranked by Revenue (2021)
4.1.2 Global Overactive Bladder (OAB) Therapeutics Revenue by Manufacturer (2017-2022)
4.1.3 Global Overactive Bladder (OAB) Therapeutics Sales by Manufacturer (2017-2022)
4.1.4 Global Overactive Bladder (OAB) Therapeutics Price by Manufacturer (2017-2022)
4.2 Global Overactive Bladder (OAB) Therapeutics Concentration Ratio (CR)
4.2.1 Overactive Bladder (OAB) Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Overactive Bladder (OAB) Therapeutics in 2021
4.2.3 Global Overactive Bladder (OAB) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Overactive Bladder (OAB) Therapeutics Manufacturing Base Distribution, Product Type
4.3.1 Global Overactive Bladder (OAB) Therapeutics Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Overactive Bladder (OAB) Therapeutics Product Type
4.3.3 Date of International Manufacturers Enter into Overactive Bladder (OAB) Therapeutics Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Overactive Bladder (OAB) Therapeutics Market Size by Company
4.5.1 Top Overactive Bladder (OAB) Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Overactive Bladder (OAB) Therapeutics Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Overactive Bladder (OAB) Therapeutics Sales by Players (2020, 2021 & 2022)
5 Global Overactive Bladder (OAB) Therapeutics Market Size by Region
5.1 Global Overactive Bladder (OAB) Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Overactive Bladder (OAB) Therapeutics Market Size in Volume by Region (2017-2028)
5.2.1 Global Overactive Bladder (OAB) Therapeutics Sales in Volume by Region: 2017-2022
5.2.2 Global Overactive Bladder (OAB) Therapeutics Sales in Volume Forecast by Region (2023-2028)
5.3 Global Overactive Bladder (OAB) Therapeutics Market Size in Value by Region (2017-2028)
5.3.1 Global Overactive Bladder (OAB) Therapeutics Sales in Value by Region: 2017-2022
5.3.2 Global Overactive Bladder (OAB) Therapeutics Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Overactive Bladder (OAB) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Overactive Bladder (OAB) Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Overactive Bladder (OAB) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Overactive Bladder (OAB) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Overactive Bladder (OAB) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Corporation Information
7.1.2 Allergan Description and Business Overview
7.1.3 Allergan Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Allergan Overactive Bladder (OAB) Therapeutics Products Offered
7.1.5 Allergan Recent Development
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporation Information
7.2.2 Astellas Pharma Description and Business Overview
7.2.3 Astellas Pharma Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Astellas Pharma Overactive Bladder (OAB) Therapeutics Products Offered
7.2.5 Astellas Pharma Recent Development
7.3 Hisamitsu Pharmaceutical
7.3.1 Hisamitsu Pharmaceutical Corporation Information
7.3.2 Hisamitsu Pharmaceutical Description and Business Overview
7.3.3 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Products Offered
7.3.5 Hisamitsu Pharmaceutical Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer Overactive Bladder (OAB) Therapeutics Products Offered
7.4.5 Pfizer Recent Development
7.5 Ferring
7.5.1 Ferring Corporation Information
7.5.2 Ferring Description and Business Overview
7.5.3 Ferring Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Ferring Overactive Bladder (OAB) Therapeutics Products Offered
7.5.5 Ferring Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporation Information
7.6.2 GlaxoSmithKline Description and Business Overview
7.6.3 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.6.4 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Products Offered
7.6.5 GlaxoSmithKline Recent Development
7.7 Ion Channel Innovations
7.7.1 Ion Channel Innovations Corporation Information
7.7.2 Ion Channel Innovations Description and Business Overview
7.7.3 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Products Offered
7.7.5 Ion Channel Innovations Recent Development
7.8 Kwang Dong Pharmaceutical
7.8.1 Kwang Dong Pharmaceutical Corporation Information
7.8.2 Kwang Dong Pharmaceutical Description and Business Overview
7.8.3 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Products Offered
7.8.5 Kwang Dong Pharmaceutical Recent Development
7.9 Lanzhou Institute of Biological Products
7.9.1 Lanzhou Institute of Biological Products Corporation Information
7.9.2 Lanzhou Institute of Biological Products Description and Business Overview
7.9.3 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Products Offered
7.9.5 Lanzhou Institute of Biological Products Recent Development
7.10 Merck
7.10.1 Merck Corporation Information
7.10.2 Merck Description and Business Overview
7.10.3 Merck Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Merck Overactive Bladder (OAB) Therapeutics Products Offered
7.10.5 Merck Recent Development
7.11 ONO Pharmaceutical
7.11.1 ONO Pharmaceutical Corporation Information
7.11.2 ONO Pharmaceutical Description and Business Overview
7.11.3 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.11.4 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Products Offered
7.11.5 ONO Pharmaceutical Recent Development
7.12 Sanofi
7.12.1 Sanofi Corporation Information
7.12.2 Sanofi Description and Business Overview
7.12.3 Sanofi Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Sanofi Products Offered
7.12.5 Sanofi Recent Development
7.13 Tengion
7.13.1 Tengion Corporation Information
7.13.2 Tengion Description and Business Overview
7.13.3 Tengion Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Tengion Products Offered
7.13.5 Tengion Recent Development
7.14 Teva Pharmaceutical Industries
7.14.1 Teva Pharmaceutical Industries Corporation Information
7.14.2 Teva Pharmaceutical Industries Description and Business Overview
7.14.3 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Teva Pharmaceutical Industries Products Offered
7.14.5 Teva Pharmaceutical Industries Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Overactive Bladder (OAB) Therapeutics Industry Chain Analysis
8.2 Overactive Bladder (OAB) Therapeutics Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Overactive Bladder (OAB) Therapeutics Distributors
8.3 Overactive Bladder (OAB) Therapeutics Production Mode & Process
8.4 Overactive Bladder (OAB) Therapeutics Sales and Marketing
8.4.1 Overactive Bladder (OAB) Therapeutics Sales Channels
8.4.2 Overactive Bladder (OAB) Therapeutics Distributors
8.5 Overactive Bladder (OAB) Therapeutics Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Overactive Bladder (OAB) Therapeutics CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Overactive Bladder (OAB) Therapeutics Market Trends
Table 3. Overactive Bladder (OAB) Therapeutics Market Drivers
Table 4. Overactive Bladder (OAB) Therapeutics Market Challenges
Table 5. Overactive Bladder (OAB) Therapeutics Market Restraints
Table 6. Global Overactive Bladder (OAB) Therapeutics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Overactive Bladder (OAB) Therapeutics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Overactive Bladder (OAB) Therapeutics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Overactive Bladder (OAB) Therapeutics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Overactive Bladder (OAB) Therapeutics Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Overactive Bladder (OAB) Therapeutics Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Overactive Bladder (OAB) Therapeutics Revenue Share by Manufacturer, 2017-2022
Table 13. Global Overactive Bladder (OAB) Therapeutics Sales by Manufacturer, (Kg), 2017-2022
Table 14. Global Overactive Bladder (OAB) Therapeutics Sales Share by Manufacturer, 2017-2022
Table 15. Global Overactive Bladder (OAB) Therapeutics Price by Manufacturer (2017-2022) & (USD/Kg)
Table 16. Global Overactive Bladder (OAB) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Overactive Bladder (OAB) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder (OAB) Therapeutics as of 2021)
Table 18. Top Players of Overactive Bladder (OAB) Therapeutics in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Overactive Bladder (OAB) Therapeutics Product Type
Table 20. Date of International Manufacturers Enter into Overactive Bladder (OAB) Therapeutics Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Overactive Bladder (OAB) Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Overactive Bladder (OAB) Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Overactive Bladder (OAB) Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Overactive Bladder (OAB) Therapeutics Sales by Players, (Kg), 2020, 2021 & 2022
Table 26. United States Overactive Bladder (OAB) Therapeutics Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Overactive Bladder (OAB) Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Overactive Bladder (OAB) Therapeutics Sales in Volume by Region (2017-2022) & (Kg)
Table 29. Global Overactive Bladder (OAB) Therapeutics Sales in Volume Forecast by Region (2023-2028) & (Kg)
Table 30. Global Overactive Bladder (OAB) Therapeutics Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Overactive Bladder (OAB) Therapeutics Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Overactive Bladder (OAB) Therapeutics Sales in Volume by Country (2017-2028) & (Kg)
Table 33. North America Overactive Bladder (OAB) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales in Volume by Region (2017-2028) & (Kg)
Table 35. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Overactive Bladder (OAB) Therapeutics Sales in Volume by Country (2017-2028) & (Kg)
Table 37. Europe Overactive Bladder (OAB) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Overactive Bladder (OAB) Therapeutics Sales in Volume by Country (2017-2028) & (Kg)
Table 39. Latin Americaa Overactive Bladder (OAB) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales in Volume by Country (2017-2028) & (Kg)
Table 41. Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Allergan Corporation Information
Table 43. Allergan Description and Business Overview
Table 44. Allergan Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 45. Allergan Overactive Bladder (OAB) Therapeutics Product
Table 46. Allergan Recent Development
Table 47. Astellas Pharma Corporation Information
Table 48. Astellas Pharma Description and Business Overview
Table 49. Astellas Pharma Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 50. Astellas Pharma Product
Table 51. Astellas Pharma Recent Development
Table 52. Hisamitsu Pharmaceutical Corporation Information
Table 53. Hisamitsu Pharmaceutical Description and Business Overview
Table 54. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 55. Hisamitsu Pharmaceutical Product
Table 56. Hisamitsu Pharmaceutical Recent Development
Table 57. Pfizer Corporation Information
Table 58. Pfizer Description and Business Overview
Table 59. Pfizer Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 60. Pfizer Product
Table 61. Pfizer Recent Development
Table 62. Ferring Corporation Information
Table 63. Ferring Description and Business Overview
Table 64. Ferring Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 65. Ferring Product
Table 66. Ferring Recent Development
Table 67. GlaxoSmithKline Corporation Information
Table 68. GlaxoSmithKline Description and Business Overview
Table 69. GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 70. GlaxoSmithKline Product
Table 71. GlaxoSmithKline Recent Development
Table 72. Ion Channel Innovations Corporation Information
Table 73. Ion Channel Innovations Description and Business Overview
Table 74. Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 75. Ion Channel Innovations Product
Table 76. Ion Channel Innovations Recent Development
Table 77. Kwang Dong Pharmaceutical Corporation Information
Table 78. Kwang Dong Pharmaceutical Description and Business Overview
Table 79. Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 80. Kwang Dong Pharmaceutical Product
Table 81. Kwang Dong Pharmaceutical Recent Development
Table 82. Lanzhou Institute of Biological Products Corporation Information
Table 83. Lanzhou Institute of Biological Products Description and Business Overview
Table 84. Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 85. Lanzhou Institute of Biological Products Product
Table 86. Lanzhou Institute of Biological Products Recent Development
Table 87. Merck Corporation Information
Table 88. Merck Description and Business Overview
Table 89. Merck Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 90. Merck Product
Table 91. Merck Recent Development
Table 92. ONO Pharmaceutical Corporation Information
Table 93. ONO Pharmaceutical Description and Business Overview
Table 94. ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 95. ONO Pharmaceutical Product
Table 96. ONO Pharmaceutical Recent Development
Table 97. Sanofi Corporation Information
Table 98. Sanofi Description and Business Overview
Table 99. Sanofi Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 100. Sanofi Product
Table 101. Sanofi Recent Development
Table 102. Tengion Corporation Information
Table 103. Tengion Description and Business Overview
Table 104. Tengion Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 105. Tengion Product
Table 106. Tengion Recent Development
Table 107. Teva Pharmaceutical Industries Corporation Information
Table 108. Teva Pharmaceutical Industries Description and Business Overview
Table 109. Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 110. Teva Pharmaceutical Industries Product
Table 111. Teva Pharmaceutical Industries Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Overactive Bladder (OAB) Therapeutics Customers List
Table 115. Overactive Bladder (OAB) Therapeutics Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Overactive Bladder (OAB) Therapeutics Product Picture
Figure 2. Global Overactive Bladder (OAB) Therapeutics Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Overactive Bladder (OAB) Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. Global Overactive Bladder (OAB) Therapeutics Sales 2017-2028 (Kg)
Figure 5. United States Overactive Bladder (OAB) Therapeutics Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Overactive Bladder (OAB) Therapeutics Market Size 2017-2028 (US$ Million)
Figure 7. United States Overactive Bladder (OAB) Therapeutics Sales 2017-2028 (Kg)
Figure 8. United States Overactive Bladder (OAB) Therapeutics Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Overactive Bladder (OAB) Therapeutics Market Share in Global, in Volume (Kg) 2017-2028
Figure 10. Overactive Bladder (OAB) Therapeutics Report Years Considered
Figure 11. Product Picture of Anticholinergic Agents
Figure 12. Product Picture of Beta-3 Adrenoreceptor Agonists
Figure 13. Global Overactive Bladder (OAB) Therapeutics Market Share by Type in 2022 & 2028
Figure 14. Global Overactive Bladder (OAB) Therapeutics Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Overactive Bladder (OAB) Therapeutics Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Overactive Bladder (OAB) Therapeutics Sales by Type (2017-2028) & (Kg)
Figure 17. Global Overactive Bladder (OAB) Therapeutics Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Overactive Bladder (OAB) Therapeutics Price by Type (2017-2028) & (USD/Kg)
Figure 19. United States Overactive Bladder (OAB) Therapeutics Market Share by Type in 2022 & 2028
Figure 20. United States Overactive Bladder (OAB) Therapeutics Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Overactive Bladder (OAB) Therapeutics Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Overactive Bladder (OAB) Therapeutics Sales by Type (2017-2028) & (Kg)
Figure 23. United States Overactive Bladder (OAB) Therapeutics Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Overactive Bladder (OAB) Therapeutics Price by Type (2017-2028) & (USD/Kg)
Figure 25. Product Picture of Hosptial
Figure 26. Product Picture of Clinci
Figure 27. Product Picture of Other
Figure 28. Global Overactive Bladder (OAB) Therapeutics Market Share by Application in 2022 & 2028
Figure 29. Global Overactive Bladder (OAB) Therapeutics Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Overactive Bladder (OAB) Therapeutics Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Overactive Bladder (OAB) Therapeutics Sales by Application (2017-2028) & (Kg)
Figure 32. Global Overactive Bladder (OAB) Therapeutics Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Overactive Bladder (OAB) Therapeutics Price by Application (2017-2028) & (USD/Kg)
Figure 34. United States Overactive Bladder (OAB) Therapeutics Market Share by Application in 2022 & 2028
Figure 35. United States Overactive Bladder (OAB) Therapeutics Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Overactive Bladder (OAB) Therapeutics Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Overactive Bladder (OAB) Therapeutics Sales by Application (2017-2028) & (Kg)
Figure 38. United States Overactive Bladder (OAB) Therapeutics Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Overactive Bladder (OAB) Therapeutics Price by Application (2017-2028) & (USD/Kg)
Figure 40. North America Overactive Bladder (OAB) Therapeutics Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 41. North America Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Overactive Bladder (OAB) Therapeutics Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 45. Europe Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Overactive Bladder (OAB) Therapeutics Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 52. Asia-Pacific Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Overactive Bladder (OAB) Therapeutics Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 64. Latin America Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 69. Middle East & Africa Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Overactive Bladder (OAB) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Overactive Bladder (OAB) Therapeutics Value Chain
Figure 74. Overactive Bladder (OAB) Therapeutics Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Industry Market Size
